Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.670
-0.040 (-2.34%)
Sep 5, 2025, 4:00 PM - Market closed
Inhibikase Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.